Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care.
- Bill Number
- H.Res. 1389
- Origin Chamber
- House
- Congress
- 119th Congress, Session 2
- Policy Area
- Health
- Status
- Introduced
- Latest Action
- 2026-06-24: Referred to the House Committee on Energy and Commerce.
- Last Updated
- 2026-07-02T20:50:13Z
AI-Generated Summary
Purpose
This resolution expresses the sense of the House of Representatives that monitoring and regulating water systems should not be used to surveil, track, detect, stigmatize, or further limit access to medication abortion care, including the drug mifepristone.
Key Provisions
- States that mifepristone is safe and effective, with approval from the Food and Drug Administration for over 25 years and support from decades of scientific evidence.
- Asserts that medications for abortion care should not face political interference.
- Emphasizes that protecting water systems must rely on science-based environmental approaches, not the politicization of reproductive health medications.
- Describes efforts to test water systems for mifepristone as a misuse of environmental laws that attacks access to medication abortion.
Significant Changes to Existing Law
As a non-binding resolution, this measure does not alter any current laws or regulations. It instead voices an opinion on the proper use of water monitoring and environmental rules in relation to reproductive health.
Potential Impacts
- Could shape discussions on how federal and state agencies, such as the Environmental Protection Agency, direct resources for water testing away from medication detection.
- May affect citizens by highlighting concerns over access to safe and affordable reproductive health options.
- Influences state-level efforts, noting over 60 bills in 22 states that target medication abortion under environmental pretexts.
Main Stakeholders Affected
- Federal agencies like the Environmental Protection Agency and Food and Drug Administration, which handle water regulation and medication approvals.
- State lawmakers introducing related bills on abortion access and water testing.
- Individuals seeking medication abortion care and reproductive health providers.
- Environmental and public health groups focused on water quality.
Notable Legal, Constitutional, or Political Implications
- Underscores political tensions around the use of environmental laws for purposes unrelated to pollution or public health, such as tracking medication use.
- References the 2022 Supreme Court decision in Dobbs v. Jackson Women's Health Organization as a backdrop for ongoing state and federal actions on abortion.
- Points to a lack of scientific basis for linking mifepristone to water system harm, based on Food and Drug Administration analyses.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Rep. Pettersen, Brittany [D-CO-7]
Recent Actions
- 2026-06-24: Referred to the House Committee on Energy and Commerce.
- 2026-06-24: Submitted in House
Bill Versions
- Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care. — issued 2026-06-24 — PDF (4 pages)